Table 5.
Flow chart of the patients included in the GIMEMA 0496 protocol
.
Clinical trial
.
Central handling
.
Evaluable integrated cytogenetic-molecular classification
.
No. patients eligible for the study
498
414
325
No. patients who started induction
490
408
317
No. patients evaluable for response
455
380
294
No. RC (%)
363 (80)
303 (80)
232 (79)
.
Clinical trial
.
Central handling
.
Evaluable integrated cytogenetic-molecular classification
.
No. patients eligible for the study
498
414
325
No. patients who started induction
490
408
317
No. patients evaluable for response
455
380
294
No. RC (%)
363 (80)
303 (80)
232 (79)
View Large
Close Modal
Close Modal
This Feature Is Available To Subscribers Only
Sign In
or
Create an Account
Close Modal
Close Modal